Protective effects of 2-methoxycinnamaldehyde an active ingredients of Cinnamomum cassia on warm hepatic ischemia reperfusion injury in rat model

• Published in: Iranian journal of basic medical sciences 2019-12, Vol.22 (12), p.1400-1407
• Main Authors: Golshahi, Hannaneh, Araghi, Atefeh, Baghban, Farshad, Farzad-Mohajeri, Saeed
• Format: Article
• Language: English
• Subjects: 2-methoxycinnamaldehyde; Apoptosis; Cell adhesion & migration; Chemokines; Cytokines; Ingredients; Ischemia; ischemia reperfusion injury; Laboratory animals; Liver; Original; Oxidative stress; Permeability; rat; Rodents; Trauma; Tumor necrosis factor-TNF; Veins & arteries; Veterinary medicine
• ISSN: 2008-3866; 2008-3874
• DOI: 10.22038/IJBMS.2019.13987

Hepatic ischemia/reperfusion injury (IRI) is one of the major causes of hepatic failure during liver transplantation, trauma, and infections. The present study investigated the protective effect of intra-portal administration of 2-methoxycinnamaldehyde (2-MCA) on hepatic IRI in rats. Twenty-four rats were equally divided into four groups; 1) sham group, (no IRI or transfusion), 2) Hepatic IRI (60 min ischemia + 120 min reperfusion, 3) Hepatic IRI+ NS (IRI + normal saline), 4) Hepatic IRI+2-MCA, (IRI + 2-MCA). In groups 3 and 4, 1 ml/kg normal saline and 2-MCA were administered slowly into the vein of the left lateral and median lobes of the liver 10 min before induction of hepatic reperfusion (upper the site of clumping), respectively. The harvest time points were at 2 hours post-reperfusion in all groups. Histologically, cell death, degenerative changes, sinusoidal dilatation, congestion, hemorrhage, and infiltration of inflammatory cells were observed in IRI group, while these pathological changes were attenuated in the 2-MCA administrated group. The level of alanine transaminase, aspartate transaminase, tumor necrosis factor- α and interleukin-6 in serum and hepatic malondialdehyde were significantly increased by IRI, and 2-MCA administration reduced all these markers. In addition, caspase-3 and nuclear factor κB (NF-κB) expression were investigated immunohistochemically. Administration of 2-MCA considerably decreased caspase-3 positive cells and NF-κB activity in comparison with IRI group. As a conclusion, in situ administration of 2-MCA protects against hepatic IRI via anti-inflammatory, and anti-apoptotic properties.